The retrovirus RNA trafficking granule: From birth to maturity

Retrovirology

Volumn 3, Issue , 2006, Pages

  Cochrane, Alan W ^a   McNally, Mark T ^b   Mouland, Andrew J ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CIS ACTING ELEMENT; DEAD BOX PROTEIN; GAG PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; POLYADENYLATED RNA; RNA BINDING PROTEIN; RNA HELICASE; STAUFEN 1 PROTEIN; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; VIRUS RNA;

3' UNTRANSLATED REGION; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL VACUOLE; CYTOPLASM; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; POLYADENYLATION; PROGENY; PROTEIN RNA BINDING; REGULATORY MECHANISM; REGULATORY RNA SEQUENCE; RETROVIRUS; REVIEW; RNA METABOLISM; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ALTERNATIVE SPLICING; ANIMALS; CELL NUCLEUS; CYTOPLASM; HUMANS; RETROVIRIDAE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA TRANSPORT; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

MIRIDAE;

EID: 33745103496     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-18     Document Type: Review

References (198)

1. Fu XD, Katz RA, Skalka AM, Maniatis T: The role of branchpoint and 3′ exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes & Development 1991:211-220.
2. Katz RA, Skalka AM: Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Molecular & Cellular Biology 1990, 10(2):696-704.
3. Zhang L, Stoltzfus CM: A suboptimal src 3′ splice site is necessary for efficient replication of Rous sarcoma virus. Virology 1995, 206(2):1099-1107.
4. Amendt BA, Simpson SB, Stoltzfus CM: Inhibition of RNA splicing at the Rous sarcoma virus src 3′ splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J Virol 1995, 69(8):5068-5076.
5. McNally MT, Beemon K: Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. Journal of Virology 1992, 66(1):6-11.
6. Arrigo S, Beemon K: Regulation of Rous sarcoma virus RNA splicing and stability. Molecular & Cellular Biology 1988, 8:4858-4867.
7. Stoltzfus CM, Fogarty SJ: Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA. Journal of Virology 1989, 63(4):1669-1676.
8. O'Sullivan CT, Polony TS, Paca RE, Beemon KL: Rous sarcoma virus negative regulator of splicing selectively suppresses SRC mRNA splicing and promotes polyadenylation. Virology 2002, 302(2):405-412.
9. McNally MT, Gontarek RR, Beemon K: Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology 1991, 185(1):99-108.
10. Hibbert CS, Gontarek RR, Beemon KL: The role of overlapping U1 and U11 5′ splice site sequences in a negative regulator of splicing. RNA 1999, 5(3):333-343.
11. McNally LM, McNally MT: U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element. Journal of Virology 1999, 73(3):2385-2393.
12. Paca RE, Hibbert CS, O'Sullivan CT, Beemon KL: Retroviral splicing suppressor requires three nonconsensus uridines in a 5′ splice site-like sequence. Journal of Virology 2001, 75(16):7763-7768.
13. Patel AA, Steitz JA: Splicing double: insights from the second spliceosome. Nat Rev Mol Cell Biol 2003, 4(12):960-970.
14. Gontarek RR, McNally MT, Beemon K: Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes & Development 1993, 7(10):1926-1936.
15. Fogel BL, McNally MT: A cellular protein, hnRNP H, binds to the negative regulator of splicing element from rous sarcoma virus. Journal of Biological Chemistry 2000, 275(41):32371-32378.
16. McNally LM, McNally MT: SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. Journal of Virology 1996, 70(2):1163-1172.
17. Cook CR, McNally MT: SR protein and snRNP requirements for assembly of the Rous sarcoma virus negative regulator of splicing complex in vitro. Virology 1998, 242:211-220.
18. Cook CR, McNally MT: Characterization of an RNP complex that assembles on the Rous sarcoma virus negative regulator of splicing element. Nucleic Acids Research 1996, 24(24):4962-4968.
19. Cook CR, McNally MT: Interaction between the negative regulator of splicing element and a 3′ splice site: requirement for U1 small nuclear ribonucleoprotein and the 3′ splice site branch point/ pyrimidine tract. Journal of Virology 1999, 73(3):2394-2400.
20. Montzka KA, Steitz JA: Additional low-abundance human small nuclear ribonucleoproteins: U11, U12, etc. Proc Natl Acad Sci U S A 1988, 85(23):8885-8889.
21. McNally LM, Yee L, McNally MT: Two regions promote U11 snRNP binding to a retroviral splicing inhibitor element (NRS). J Biol Chem 2004, 204:38201-38208.
22. McNally LM, Yee L, McNally MT: Heterogeneous nuclear ribonucleoprotein H is required for optimal U11 small nuclear ribonucleoprotein binding to a retroviral RNA-processing control element: implications for U12-dependent RNA splicing. J Biol Chem 2006, 281(5):2478-2488.
23. Caputi M, Zahler AM: SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. Embo J 2002, 21(4):845-855.
24. Han K, Yeo G, An P, Burge CB, Grabowski PJ: A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol 2005, 3(5):e158.
25. Garneau D, Revil T, Fisette JF, Chabot B: Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x. J Biol Chem 2005, 280(24):22641-22650.
26. Tang H, Kuhen KL, Wong-Staal F: Lentivirus replication and regulation. Annual Review of Genetics 1999, 33:133-170.
27. Schwartz S, Felber BK, Benko DM, Fenyo EM, Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. Journal of Virology 1990, 64:2519-2529.
28. Purcell D, Martin MA: Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993, 67:6365-6378.
29. O'Reilly M, McNally M, Beemon K: Two strong 5′ splice sites and competing 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 1995, 213:373-385.
30. Si Z, Amendt BA, Stoltzfus CM: Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Research 1997, 25(4):861-867.
31. Staffa A, Cochrane A: The tat/rev Intron of Human Immunodeficiency Virus Type 1 Is Inefficiently Spliced because of Suboptimal Signals in the 3′ Splice Site. Journal of Virology 1994, 68:3071-3079.
32. Amendt B, Si Z, Stoltzfus CM: Presence of Exon Splicing Silencers within Human Immunodeficiency Virus Type 1 tat Exon 2 and tat-rev Exon 3: Evidence for Inhibition Mediated by Cellular Factors. Molecular and Cellular Biology 1995, 15:4606-4615.
33. Amendt BA, Hesslein D, Chang LJ, Stoltzfus CM: Presence of Negative and Positive cis-Acting RNA Splicing Elements within and Flanking the First tat Coding Exon of Human Immunodeficiency Virus Type 1. Molecular and Cellular Biology 1994, 14:3960-3970.
34. Bilodeau PS, Domsic JK, Mayeda A, Krainer AR, Stoltzfus CM: RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. Journal of Virology 2001, 75(18):8487-8497.
35. Jacquenet S, Mereau A, Bilodeau PS, Damier L, Stoltzfus C, Branlant C: A Second Exon Splicing Silencer within the Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H. J Biol Chem 2001, 276:40464-40475.
36. Si ZH, Rauch D, Stoltzfus M: The Exon Splicing Silencer in the Human Immunodeficiency Virus Type 1 Tat Exon 3 Is Bipartite and Acts Early in Spliceosome Assembly. Molecular and Cellular Biology 1998, 18:5404-5413.
37. Staffa A, Cochrane A: Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Molecular and Cellular Biology 1995, 15:4597-4605.
38. Domsic JK, Wang Y, Mayeda A, Krainer AR, Stoltzfus CM: Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts. Molecular & Cellular Biology 2003, 23(23):8762-8772.
39. Caputi M, Mayeda A, Krainer AR, Zahler AM: hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. Embo J 1999, 18(14):4060-4067.
40. Asai K, Platt C, Cochrane A: Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function. Virology 2003, 314(1):229-242.
41. Zhu J, Mayeda A, Krainer A: Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Molecular Cell 2001, 8(6):1351-1361.
42. Marchand V, Mereau A, Jacquenet S, Thomas D, Mougin A, Gattoni R, Stevenin J, Branlant C: A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. Journal of Molecular Biology 2002, 323(4):629-652.
43. Tange TO, Damgaard CK, Guth S, Valcarcel J, Kjems J: The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO Journal 2001, 20(20):5748-5758.
44. Blanchette M, Chabot B: Modulation of exon skipping by high affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO Journal 1999, 18:1939-1952.
45. Nasim FU, Hutchison S, Cordeau M, Chabot B: High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5′ splice site selection in support of a common looping out and repression mechanism. Rna 2002, 8(8):1078-1089.
46. Caputi M, Freund M, Kammler S, Asang C, Schaal H: A bidirectional SF2/ ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. Journal of Virology 2004, 78(12):6517-6526.
47. Kammler S, Leurs C, Freund M, Krummheuer J, Seidel K, Tange TO, Lund MK, Kjems J, Scheid A, Schaal H: The sequence complementarity between HIV-1 5′ splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA 2001, 7(3):421-434.
48. Mayeda A, Screaton G, Chandler S, Fu XD, Krainer A: Substrate Specificities of SR Proteins In Constitutive Splicing Are Determined by Their RNA Recognition Motifs and Composite pre-mRNA Exonic Elements. Molecular and Cellular Biology 1999, 19:1853-1863.
49. Tange TO, Kjems J: SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. Journal of Molecular Biology 2001, 312(4):649-662.
50. Zahler AM, Damgaard CK, Kjems J, Caputi M: SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. Journal of Biological Chemistry 2004, 279(11):10077-10084.
51. Manley JL, Tacke R: SR proteins and splicing control. Genes and Development 1996, 10:1569-1579.
52. Zahler AM, Lane WS, Stolk JA, Roth MB: SR proteins: a conserved family of pre-mRNA splicing factors. Genes and Development 1992, 6:837-847.
53. Zahler AM, Neugebauer KM, Lane WS, Roth MB: Distinct Functions of SR Proteins in Alternative Pre-mRNA Splicing. Science 1993, 260:219-222.
54. Graveley BR: Sorting out the complexity of SR protein functions. RNA 2000, 6(9):1197-1211.
55. Jacquenet S, Decimo D, Muriaux D, Darlix JL: Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2005, 2(1):33.
56. Ropers D, Ayadi L, Gattoni R, Jacquenet S, Damier L, Branlant C, Stevenin J: Differential effects of the SR proteins 9G8, SC35, ASF/SF2 and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J Biol Chem 2004, 279:29963-29973.
57. Wentz MP, Moore BE, Cloyd MW, Berget SM, Donehower LA: A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. Journal of Virology 1997, 71(1):8542-8551.
58. Liao HJ, Baker CC, Princler GL, Derse D: cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing. Virology 2004, 323(1):131-140.
59. Belshan M, Park GS, Bilodeau P, Stoltzfus CM, Carpenter S: Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs. Mol Cell Biol 2000, 20(10):3550-3557.
60. Chung H, Derse D: Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA. J Biol Chem 2001, 276(22):18960-18967.
61. Gontarek RR, Derse D: Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol Cell Biol 1996, 16(5):2325-2331.
62. Cereseto A, Berneman Z, Koralnik I, Vaughn J, Franchini G, Klotman ME: Differential expression of alternatively spliced pX mRNAs in HTLV-1-infected cell lines. Leukemia 1997, 11(6):866-870.
63. Princler GL, Julias JG, Hughes SH, Derse D: Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology 2003, 317(1):136-145.
64. Kress E, Baydoun HH, Bex F, Gazzolo L, Duc Dodon M: Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytes. Retrovirology 2005, 2(1):8.
65. Xu Y, Reddy TR, Fischer WH, Wong-Staal F: A Novel hnRNP Specifically Interacts with HIV-1 RRE RNA. Journal of Biomedical Science 1996, 3(2):82-91.
66. Oshima M, Odawara T, Hanaki K, Igarashi H, Yoshikura H: cis Elements required for high-level expression of unspliced Gag-containing message in Moloney murine leukemia virus. J Virol 1998, 72(8):6414-6420.
67. Hoshi S, Odawara T, Oshima M, Kitamura Y, Takizawa H, Yoshikura H: cis-Elements involved in expression of unspliced RNA in Moloney murine leukemia virus. Biochem Biophys Res Commun 2002, 290(3):1139-1144.
68. Hwang LS, Park J, Gilboa E: Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA. Mol Cell Biol 1984, 4(11):2289-2297.
69. Aagaard L, Rasmussen SV, Mikkelsen JG, Pedersen FS: Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions. Virology 2004, 318(1):360-370.
70. Lee JT, Yu SS, Han E, Kim S, Kim S: Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector. Gene Ther 2004, 11(1):94-99.
71. Zheng YH, Yu HF, Peterlin BM: Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol 2003, 5(7):611-618.
72. Das AT, Klaver B, Berkhout B: A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. Journal of Virology 1999, 73(1):81-91.
73. Klasens BI, Thiesen M, Virtanen A, Berkhout B: The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Research 1999, 27(2):446-454.
74. Vagner S, Ruegsegger U, Gunderson SI, Keller W, Mattaj IW: Position-dependent inhibition of the cleavage step of pre-mRNA 3′-end processing by U1 snRNP. Rna-A Publication of the Rna Society 2000, 6(2):178-188.
75. Ashe MP, Furger A, Proudfoot NJ: Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation. Rna-A Publication of the Rna Society 2000, 6(2):170-177.
76. Ashe MP, Pearson LH, Proudfoot NJ: The HIV-1 5′ LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO Journal 1997. 16(18):5752-5763.
77. Gunderson SI, Polycarpou-Schwarz M, Mattaj IW: U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Molecular Cell 1998, 1(2):255-264.
78. Pongoski J, Asai K, Cochrane A: Positive and Negative Modulation of Human Immunodeficiency Virus Type 1 Rev Function by cis and trans Regulators of Viral RNA Splicing. J Virol 2002, 76(10):5108-5120.
79. McLaren M, Asai K, Cochrane A: A novel function for Sam68: Enhancement of HIV-1 RNA 3′ end processing. RNA 2004, 10:1119-1129.
80. Reddy TR, Xu W, Wong-Staal F: General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses. Oncogene 2000, 19:4071-4074.
81. Reddy T, Xu W, Mau J, Goodwin C, Suhasini M, Tang H, Frimpong K, Rose D, Wong-Staal F: Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev. Nature Medicine 1999, 5:635-642.
82. Reddy TR, Suhasini M, Xu W, Yeh LY, Yang JP, Wu J, Artzt K, Wong-Staal F: A role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication. Journal of Biological Chemistry 2002, 277(8):5778-5784.
83. Soros V, Valderrarama Carvajal H, Richard S, Cochrane A: Inhibition of Human Immunodeficiency Virus Type 1 Rev Function by a Dominant-Negative Mutant of Sam68 through Sequestration of Unspliced RNA at Perinuclear Bundles. J Virol 2001, 75:8203-8215.
84. Modem S, Badri KR, Holland TC, Reddy TR: Sam68 is absolutely required for Rev function and HIV-1 production. Nucleic Acids Research 2005, 33(3):873-879.
85. Mouland AJ, Coady M, Yao XJ, Cohen EA: Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression. Virology 2002, 292(2):321-330.
86. Calzado MA, Sancho R, Munoz E: Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression. Journal of Virology 2004, 78(13):6846-6854.
87. Furger A, Monks J, Proudfoot NJ: The retroviruses human immunodeficiency virus type 1 and Moloney murine leukemia virus adopt radically different strategies to regulate promoter-proximal polyadenylation. J Virol 2001. 75(23):11735-11746.
88. Herman SA, Coffin JM: Differential transcription from the long terminal repeats of integrated avian leukosis virus DNA. J Virol 1986, 60(2):497-505.
89. Miller JT, Stoltzfus CM: Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3′-end processing of avian sarcoma virus RNA. Journal of virology 1992, 66(7):4242-4251.
90. Fogel BL, McNally LM, McNally MT: Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element. Nucleic Acids Research 2002, 30(3):810-817.
91. Polony TS, Bowers SJ, Neiman PE, Beemon KL: Silent point mutation in an avian retrovirus RNA processing element promotes c-myb-associated short-latency lymphomas. J Virol 2003, 77(17):9378-9387.
92. Dimaano C, Ullman KS: Nucleocytoplasmic transport: integrating mRNA production and turnover with export through the nuclear pore. Mol Cell Biol 2004, 24(8):3069-3076.
93. Cullen BR: Nuclear RNA export. Journal of Cell Science 2003, 116(Pt 4):587-597.
94. Cullen B: HIV-1 Auxiliary Proteins: Making Connections in a Dying Cell. Cell 1998, 93:685-692.
95. Hope TJ: The ins and outs of HIV Rev. Archives of Biochemistry & Biophysics 1999, 365:186-191.
96. Pollard V, Malim M: The HIV-1 Rev Protein. Annual Review of Microbiology 1998, 52:491-532.
97. Chang DD, Sharp PA: Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989, 59:789-795.
98. Brighty DW, Rosenberg M: A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splicing signals. Proceedings of the National Academy of Sciences of the United States if America 1994, 91:8314-8318.
99. Cochrane AW, ]ones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA: Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. Journal of Virology 1991, 65:5305-5313.
100. Keller R, Montagnier L, Cordonnier A: Characterization of a Nuclear Retention Sequence within the 3′ Region of the HIV-2 Envelope Gene. Virology 1993, 192:33-37.
101. Maldarelli F, Martin MA, Strebel K: Identification of post-transcriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. Journal of Virology 1991, 65:5732-5743.
102. Mikaelian I, Krieg M, Gait M, Karn J: Interactions of INS (CRS) Elements and the Splicing Machinery Regulate the Production of Rev-responsive mRNAs. Journal of Molecular Biology 1996, 257:246-264.
103. Schwartz S, Felber BK, Pavlakis GN: Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decreases RNA stability and inhibit expression in the absence of Rev protein. Journal of Virology 1992, 66:150-159.
104. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber B, Pavlakis G: Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. Journal of Virology 1992, 66:7176-7182.
105. Seguin B, Staffa A, Cochrane A: Control of HIV-1 RNA Metabolism: The Role of Splice Sites and Intron Sequences in Unspliced Viral RNA Subcellular Distribution. Journal of Virology 1998, 72:9503-9513.
106. Nasioulas G, Zolotukhin A, Tabernero C, Solomin L, Cunningham C, Pavlakis G, Felber B: Elements Distinct from Human Immunodeficiency Virus Type 1 Splice Sites Are Responsible for the Rev Dependence of env mRNA. Journal of Virology 1994, 68:2986-2993.
107. Graf M, Bojak A, Deml L, Bieler H, Wolf H, Wagner R: Concerted Action of Multiple cis-acting Sequences Is Required for Rev Dependence of Late Human Immunodeficiency Virus Type 1 Gene Expression. J Virol 2000, 74:10822-10826.
108. Iacampo S, Cochrane A: Human Immunodeficiency Virus Type 1 Rev Function Requires Continued Synthesis of Its Target mRNA. Journal of Virology 1996, 70:8332-8339.
109. Huang Y, Carmichael GC: Role of polyadenylation in nucleocytoplasmic transport of mRNA. Molecular & Cellular Biology 1996, 16(4):1534-1542.
110. Maniatis T, Reed R: An extensive network of coupling among gene expression machines. Nature 2002, 416(6880):499-506.
111. Reed R: Coupling transcription, splicing and mRNA export. Current Opinion in Cell Biology 2003, 15(3):326-331.
112. Vasudevan S, Peltz SW: Nuclear mRNA surveillance. Current Opinion in Cell Biology 2003, 15(3):332-337.
113. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT: Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119(3):381-392.
114. Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ: A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004, 330(2):471-480.
115. Yu Z, Sanchez-Velar N, Catrina IE, Kittler EL, Udofia EB, Zapp ML: The cellular HIV-1 Rev cofactor hRIP is required for viral replication. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(11):4027-4032.
116. Sanchez-Velas N, Udofia I, Yu Z, Zapp M: hRIP, a cellular cofactor for Rev function, promotes release of HIV-1 RNAs from the perinuclear region. Genes & Dev 2004, 18:23-34.
117. Bray M, Prasad S, Dubay JW, Hunter E, Jeang KT, Rekosh D, Hammarskjold ML: A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev- independent. Proc Natl Acad Sci U S A 1994, 91(4):1256-1260.
118. Ernst RK, Bray M, Rekosh D, Hammarskjold ML: A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Molecular & Cellular Biology 1997, 17(1):135-144.
119. Hammarskjold ML, Li H, Rekosh D, Prasad S: Human Immunodeficiency Virus env Expression Becomes Rev-Independent if the env Region Is Not Defined as an Intron. Journal of Virology 1994, 68:951-958.
120. Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK: Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 1994, 68(12):7944-7952.
121. Pasquinelli AE, Ernst RK, Lund E, Grimm C, Zapp ML, Rekosh D, Hammarskjold ML, Dahlberg JE: The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. Embo J 1997, 16(24):7500-7510.
122. Saavedra C, Felber B, Izaurralde E: The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol 1997, 7(9):619-628.
123. Gruter P, Tabernero C, von Kobbe C, Schmitt C, Saavedra C, Bachi A, Wilm M, Felber B, Izauralde E: TAP, the Human Homolog of Mex67p, Mediates CTE-Dependent RNA Export from the Nucleus. Molecular Cell 1998, 1:649-659.
124. Ogert RA, Lee LH, Beemon KL: Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. Journal of Virology 1996, 70(6):3834-3843.
125. Yang J, Cullen BR: Structural and functional analysis of the avian leukemia virus constitutive transport element. Rna 1999, 5(12):1645-1655.
126. Simpson SB, Zhang L, Craven RC, Stoltzfus CM: Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle. J Virol 1997, 71(12):9150-9156.
127. Simpson SB, Guo W, Winistorfer SC, Craven RC, Stoltzfus CM: The upstream, direct repeat sequence of Prague A Rous sarcoma virus is deficient in mediating efficient Gag assembly and particle release. Virology 1998, 247(1):86-96.
128. Paca RE, Ogert RA, Hibbert CS, Izaurralde E, Beemon KL: Rous sarcoma virus DR posttranscriptional elements use a novel RNA export pathway. Journal of Virology 2000, 74(20):9507-9514.
129. Tange TO, Nott A, Moore MJ: The ever-increasing complexities of the exon junction complex. Curr Opin Cell Biol 2004, 16(3):279-284.
130. Berberich SL, Macias M, Zhang L, Turek LP, Stoltzfus CM: Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in non-permissive mouse cells [published erratum appears in J Virol 1990 Dec;64(12):6360]. Journal of Virology 1990, 64(9):4313-4320.
131. Vogt VM, Bruckenstein DA, Bell AP: Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells. J Virol 1982, 44(2):725-730.
132. Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH: Retroviral mRNA nuclear export elements regulate protein function and virion assembly. Embo J 2004, 23(13):2632-2640.
133. Beriault V, Clement JF, Levesque K, Lebel C, Yong X, Chabot B, Cohen EA, Cochrane AW, Rigby WF, Mouland AJ: A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization. J Biol Chem 2004, 279(42):44141-44153.
134. Butsch M, Boris-Lawrie K: Destiny of unspliced retroviral RNA: ribosome and/or virion? J Virol 2002, 76(7):3089-3094.
135. Kaye JF, Lever AM: Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. Journal of Virology 1999, 73(4):3023-3031.
136. Poon DT, Chertova EN, Ott DE: Human Immunodeficiency Virus Type 1 Preferentially Encapsidates Genomic RNAs That Encode Pr55(Gag): Functional Linkage between Translation and RNA Packaging. Virology 2002, 293(2):368-378.
137. Levin JG, Rosenak MJ: Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci U S A 1976, 73(4):1154-1158.
138. Butsch M, Boris-Lawrie K: Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J Virol 2000, 74(24):11531-11537.
139. Poole E, Strappe P, Mok HP, Hicks R, Lever AM: HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 2005, 6(9):741-755.
140. Muriaux D, Mirro J, Harvin D, Rein A: RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A 2001, 98(9):5246-5251.
141. Ott DE, Coren LV, Gagliardi TD: Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J Virol 2005, 79(22):13839-13847.
142. Sfakianos JN, LaCasse RA, Hunter E: The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic 2003, 4(10):660-670.
143. Sfakianos JN, Hunter E: M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 2003, 4(10):671-680.
144. Derdowski A, Ding L, Spearman P: A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag 1 domain mediates Gag-Gag interactions. J Virol 2004, 78(3):1230-1242.
145. Larson DR, Ma YM, Vogt VM, Webb WW: Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy. J Cell Biol 2003, 162(7):1233-1244.
146. Mouland AJ, Cohen A, DesGroseillers L: Trafficking of HIV-1 RNA: Recent Progress Involving Host Cell RNA-Binding Proteins. Current Genomics 2003, 4(3):196.
147. Fusco D, Accornero N, Lavoie B, Shenoy SM, Blanchard JM, Singer RH, Bertrand E: Single mRNA molecules demonstrate probabilistic movement in living Mammalian cells. Current Biology 2003, 13(2):161-167.
148. Basyuk E, Galli T, Mougel M, Blanchard JM, Sitbon M, Bertrand E: Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Developmental Cell 2003, 5(1):161-174.
149. Basyuk E, Boulon S, Skou Pedersen F, Bertrand E, Vestergaard Rasmussen S: The packaging signal of MLV is an integrated module that mediates intracellular transport of genomic RNAs. J Mol Biol 2005, 354(2):330-339.
150. Hoek KS, Kidd GJ, Carson JH, Smith R: hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin basic protein mRNA. Biochemistry 1998, 37(19):7021-7029.
151. Mouland AJ, Xu H, Cui H, Krueger W, Munro TP, Prasol M, Mercier J, Rekosh D, Smith R, Barbarese E, Cohen EA, Carson JH: RNA trafficking signals in human immunodeficiency virus type 1. Mol Cell Biol 2001, 21(6):2133-2143.
152. Kiebler MA, DesGroseillers L: Molecular insights into mRNA transport and local translation in the mammalian nervous system. Neuron 2000, 25(1):19-28.
153. Barbarese E, Koppel DE, Deutscher MP, Smith CL, Ainger K, Morgan F. Carson JH: Protein translation components are colocalized in granules in oligodendrocytes. J Cell Sci 1995, 108(Pt 8): 2781-2790.
154. Shav-Tal Y, Singer RH: RNA localization. J Cell Sci 2005, 118(Pt 18): 4077-4081.
155. Mingle LA, Okuhama NN, Shi J, Singer RH, Condeelis J, Liu G: Localization of all seven messenger RNAs for the actin-polymerization nucleator Arp2/3 complex in the protrusions of fibroblasts. J Cell Sci 2005, 118(Pt 11):2425-2433.
156. Reddy TR, Tang H, Xu W, Wong-Staal F: Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene 2000, 19(32):3570-3575.
157. Li J, Tang H, Mullen TM, Westberg C, Reddy TR, Rose DW, Wong-Staal F: A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc Natl Acad Sci U S A 1999, 96(2):709-714.
158. Tang H, Wong-Staal F: Specific interaction between RNA helicase A and Tap, two cellular proteins that bind to the constitutive transport element of type D retrovirus. J Biol Chem 2000, 275(42):32694-32700.
159. Krishnan V, Zeichner SL: Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication. Retrovirology 2004, 1(1):42.
160. Kanai Y, Dohmae N, Hirokawa N: Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 2004, 43(4):513-525.
161. Reichert VL, Le Hir H, Jurica MS. Moore MJ: 5′ exon interactions within the human spliceosome establish a framework for exon junction complex structure and assembly. Genes & Development 2002, 16(21):2778-2791.
162. Monshausen M, Gehring NH, Kosik KS: The mammalian RNA-binding protein Staufen2 links nuclear and cytoplasmic RNA processing pathways in neurons. Neuromolecular Med 2004, 6(2-3): 127-144.
163. Shyu AB, Wilkinson MF: The double lives of shuttling mRNA binding proteins. Cell 2000, 102(2):135-138.
164. Stoltzfus CM, Madsen JM: Role of Viral Splicing Elements and Cellular RNA Binding Proteins in Regulation of HIV-1 Alternative RNA Splicing. Curr HIV Res 2006, 4(1):43-55.
165. Najera I, Krieg M, Karn J: Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. J Mol Biol 1999, 285(5):1951-1964.
166. Ainger K, Avossa D, Diana AS, Barry C, Barbarese E, Carson JH: Transport and localization elements in myelin basic protein mRNA. J Cell Biol 1997, 138(5):1077-1087.
167. Kosturko LD, Maggipinto MJ, D'Sa C, Carson JH, Barbarese E: The Microtubule-associated Protein, TOG, Binds to the RNA Trafficking Protein, hnRNP A2. Mol Biol Cell 2005.
168. Tang Y, Winkler U, Freed EO, Torrey TA, Kim W, Li H, Goff SP, Morse HC: Cellular motor protein KIF-4 associates with retroviral Gag. J Virol 1999, 73(12):10508-10513.
169. Kim W, Tang Y, Okada Y, Torrey TA, Chattopadhyay SK, Pfleiderer M, Falkner FG, Dorner F, Choi W, Hirokawa N, Morse HC: Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. J Virol 1998, 72(8):6898-6901.
170. Kohrmann M, Luo M, Kaether C, DesGroseillers L, Dotti CG, Kiebler MA: Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 1999, 10(9):2945-2953.
171. Mallardo M, Deitinghoff A, Muller J, Goetze B, Macchi P, Peters C, Kiebler MA: From the Cover: Isolation and characterization of Staufen-containing ribonucleoprotein particles from rat brain. Proc Natl Acad Sci U S A 2003, 100(4):2100-2105.
172. Chatel-Chaix L, Clément JF, Martel C, Bériault V, Gatignol A, DesGroseillers L, Mouland AJ: Staufen is part of the HIV-1 Gag Ribonucleoprotein complex and is involved in the generation of infectious viral particles. Molecular and Cellular Biology 2004, 24(7):2637-2648.
173. Ferrandon D, Koch I, Westhof E, Nusslein-Volhard C: RNA-RNA interaction is required for the formation of specific bicoid mRNA 3′ UTR-STAUFEN ribonucleoprotein particles. EMBO Journal 1997, 16(7):1751-1758.
174. Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J: Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol 2004, 2(6):461-472.
175. Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA: The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol 2000, 74(12):5441-5451.
176. Soret J, Bakkour N, Maire S, Durand S, Zekri L, Gabut M, Fic W, Divita G, Rivalle C, Dauzonne D, Nguyen CH, Jeanteur P. Tazi J: Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc Natl Acad Sci U S A 2005, 102(24):8764-8769.
177. Daniel R, Pomerantz RJ: ATM: HIV-1's Achilles heel? Nat Cell Biol 2005, 7(5):452-453.
178. Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC: Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)- containing retroviral RNAs. An unexpected role for actin. J Cell Biol 2001, 152(5):895-910.
179. Liu B, Dai R, Tian CJ, Dawson L, Gorelick R, Yu XF: Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J Virol 1999, 73(4):2901-2908.
180. Wilk T, Gowen B, Fuller SD: Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J Virol 1999, 73(3):1931-1940.
181. Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE: Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266(1):42-51.
182. Cimarelli A, Luban J: Translation elongation factor I-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol 1999, 73(7):5388-5401.
183. Bevec D, Jaksche H, Oft M, Wohl T, Himmelspach M, Pacher A, Schebesta M, Koettnitz K, Dobrovnik M, Csonga R, Lottspeich F, Hauber J: Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor elF-5A. Science 1996, 271(5257):1858-1860.
184. Gurer C, Cimarelli A, Luban J: Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol 2002, 76(9):4666-4670.
185. Gurer C, Hoglund A, Hoglund S, Luban J: ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity. J Virol 2005, 79(9):5557-5567.
186. Agostini I, Popov S, Li J, Dubrovsky L, Hao T, Bukrinsky M: Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp Cell Res 2000, 259(2):398-403.
187. Iordanskiy S, Zhao Y, Dubrovsky L, Iordanskaya T, Chen M, Liang D, Bukrinsky M: Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol 2004, 78(18):9697-9704.
188. Bacharach E, Gonsky J, Alin K, Orlova M, Goff SP: The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly. J Virol 2000, 74(23):11027-11039.
189. Ueno T, Tokunaga K, Sawa H, Maeda M, Chiba J, Kojima A, Hasegawa H, Shoya Y, Sata T, Kurata T, Takahashi H: Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol Immunol 2004, 48(2):111-118.
190. Afonina E, Neumann M, Pavlakis GN: Preferential binding of poly(A)-binding protein 1 to an inhibitory RNA element in the human immunodeficiency virus type 1 gag mRNA. J Biol Chem 1997, 272(4):2307-2311.
191. Zolotukhin AS, Michalowski D, Bear J, Smulevitch SV, Traish AM, Peng R, Patton J, Shatsky IN, Felber BK: PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Molecular & Cellular Biology 2003, 23(18):6618-6630.
192. Wortman MJ, Krachmarov CP, Kim JH, Gordon RG, Chepenik LG, Brady JN, Gallia GL, Khalili K, Johnson EM: Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding. J Cell Biochem 2000, 77(1):65-74.
193. Chepenik LG, Tretiakova AP, Krachmarov CP, Johnson EM, Khalili K: The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene 1998, 210(1):37-44.
194. Krachmarov CP, Chepenik LG, Barr-Vagell S, Khalili K, Johnson EM: Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc Natl Acad Sci U S A 1996, 93(24):14112-14117.
195. Cen S, Khorchid A, Javanbakht H, Gabor J, Stello T, Shiba K, Musier-Forsyth K, Kleiman L: Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J Virol 2001, 75(11):5043-5048.
196. Lama J, Trono D: Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3. J Virol 1998, 72(2):1671-1676.
197. Villace P, Marion RM, Ortin J: The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res 2004, 32(8):2411-2420.
198. Giles KE, Beemon KL: Retroviral splicing suppressor sequesters a 3′ splice site in an ∼50S aberrant splicing complex. Mol Cell Biol 2005, 25:4397-4405.